Equities analysts expect Insulet Co. (NASDAQ:PODD – Get Rating) to report $0.22 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Insulet’s earnings, with the lowest EPS estimate coming in at $0.13 and the highest estimate coming in at $0.39. Insulet reported earnings of $0.10 per […]
InfuSystem (NYSE:INFU – Get Rating) and Insulet (NASDAQ:PODD – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Institutional and Insider Ownership 61.4% of InfuSystem shares are held by institutional […]
Equities research analysts forecast that Insulet Co. (NASDAQ:PODD – Get Rating) will post earnings per share (EPS) of $0.22 for the current quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Insulet’s earnings, with estimates ranging from $0.13 to $0.39. Insulet posted earnings per share of $0.10 in the same quarter last year, […]
Insulet (NASDAQ:PODD – Get Rating) announced its quarterly earnings data on Thursday. The medical instruments supplier reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.17, MarketWatch Earnings reports. The firm had revenue of $295.40 million during the quarter, compared to the consensus estimate of $287.99 million. Insulet had a net […]
Insulet (NASDAQ:PODD – Get Rating) had its price target decreased by Wells Fargo & Company from $357.00 to $345.00 in a research note issued to investors on Friday, The Fly reports. Wells Fargo & Company‘s target price indicates a potential upside of 52.04% from the stock’s previous close. PODD has been the topic of several […]